A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 2, 2011, Pages 175-180

  Marioni, Gino ^a   Staffieri, Alberto ^a   Manzato, Enzo ^a,b   Ralli, Giovanni ^c   Lionello, Marco ^a   Giacomelli, Luciano ^a   Prosenikliev, Vlatko ^a   Marchese Ragona, Rosario ^a   Busnardo, Alessandra ^a   Bolzetta, Francesco ^a   Blandamura, Stella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DENSITY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVESSEL DENSITY; PROGNOSIS;

AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MICROVESSELS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79952026683     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.244     Document Type: Article

References (22)

1. Balducci L, Ershler WB. Cancer and ageing: a nexus at several levels. Nat Rev Cancer. 2005;5(8):655-662. (Pubitemid 41081391)
2. Reed MJ, Edelberg JM. Impaired angiogenesis in the aged. Sci Aging Knowledge Environ. 2004;2004(7):pe7.
3. Chandrachud LM, Pendleton N, Chisholm DM, Horan MA, Schor AM. Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer. 1997;76(10):1367-1375. (Pubitemid 27474981)
4. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol. 2004;17(2):197-203. (Pubitemid 41656516)
5. Tanaka F, Ishikawa S, Yanagihara K, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res. 2002;62(23):7124-7129. (Pubitemid 35424109)
6. Fonsatti E, Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med. 2004;2(1):18.
7. Reed MJ, Karres N, Eyman D, Cruz A, Brekken RA, Plymate S. The effects of ag- ing on tumor growth and angiogenesis are tumor-cell dependent. Int J Cancer. 2007;120(4):753-760. (Pubitemid 46175393)
8. Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev. 2006;32(7):504-515. (Pubitemid 44488046)
9. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer, eds. 6th ed. Cancer Staging Manual. New York, NY: Springer; 2002.
10. Jones AS, Beasley N, Houghton D, Husband DJ. The effects of age on survival and other parameters in squamous cell carcinoma of the oral cavity, pharynx and larynx. Clin Otolaryngol Allied Sci. 1998;23(1):51-56. (Pubitemid 28344937)
11. Marioni G, Ottaviano G, Giacomelli L, et al. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. Eur J Surg Oncol. 2006;32(10):1149-1153. (Pubitemid 44774411)
12. Marioni G, Giacomelli L, D'Alessandro E, et al. Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression. Anticancer Res. 2008;28(1B):551-557. (Pubitemid 351362869)
13. Marioni G, D'Alessandro E, Giacomelli L, et al. Maspin nuclear localization is related to reduced density of tumour-associated micro-vessels in laryngeal carcinoma. Anticancer Res. 2006;26(6C):4927-4932. (Pubitemid 46032136)
14. Zvrko E, Mikic A, Vuckovic L. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2009;266(12):1971-1976.
15. Zvrko E, Mikic A, Vuckovic L. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma. Auris Nasus Larynx. 2010;37(1):77-83.
16. Bojovic B, Crowe DL. Chronologic aging decreases tumor angiogenesis and metastasis in a mouse model of head and neck cancer. Int J Oncol. 2010;36(3):715-723.
17. Fisher CJ, Egan MK, Smith P, Wicks K, Millis RR, Fentiman IS. Histopathology of breast cancer in relation to age. Br J Cancer. 1997;75(4):593-596. (Pubitemid 27085305)
18. Marinho A, Soares R, Ferro J, Lacerda M, Schmitt FC. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol Res Pract. 1997;193(4):267-273. (Pubitemid 27399700)
19. Kondou M, Nagayasu T, Hidaka S, et al. Correlation between angiogenesis and p53 expression in lung adenocarcinoma of young patients. Tohoku J Exp Med. 2009;217(2):101-107.
20. Shiozaki K, Harada N, Greco WR, et al. Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicin. Cancer Immunol Immunother. 2006;55(2):140-150. (Pubitemid 41682586)
21. Tan GH, Wei YQ, Tian L, et al. Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol. 2004;34(7):2012-2021. (Pubitemid 39256082)
22. Tan GH, Tian L, Wei YQ, et al. Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer. 2004;112(4):701-706. (Pubitemid 39425953)